Table 8 Sensitivity analysis—model with original data vs model with duration of epidemic reduced by 20%
| Â | No reduction of days (original DRC) | ||
|---|---|---|---|
| Â | No vaccination | H0G5 (Vaccine efficacy 30%) | H0G5 (Vaccine efficacy 90%) |
Cumulative cases (IQR; 95%CI) | 2782 (700–4026; 54–9637) | 1383 (302–2005; 48–5149) | 1028 (228–1467; 47–3910) |
Proportion of cases averted vs no vaccination (IQR; 95%CI) |  | 50% (48–55%; 13–58%) | 63% (61–67%; 13–70%) |
| Â | 20% reduction of days (DRC) | ||
|---|---|---|---|
| Â | No vaccination | H0G5 (Vaccine efficacy 30%) | H0G5 (Vaccine efficacy 90%) |
Cumulative cases (IQR; 95%CI) | 1711 (498–2449; 56–5823) | 957 (248–1352; 48–3368) | 757 (202–1092; 44–2631) |
Proportion of cases averted vs no vaccination (IQR; 95%CI) |  | 44% (43–46%; 13–51%) | 56% (54–59%; 21–61%) |